Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira

Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira

Source: 
CP Wire
snippet: 
  • Switching to Tremfya at week 28 after inadequate response to Humira, led to a sustained improvement
  • Tremfya is a human monoclonal antibody